Global Sanger Sequencing Service Supply, Demand and Key Producers, 2026-2032

The global Sanger Sequencing Service market size is expected to reach $ 218 million by 2032, rising at a market growth of -0.1% CAGR during the forecast period (2026-2032).

DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.

Global Sanger Sequencing Service key players include Thermo Fisher, Eurofins Scientific, and Azenta. The top three producers together hold over 40% of the market share, with Thermo Fisher being the largest producer with 16%. In terms of product categories, PCR products have the largest market share with 44%, followed by plasmid DNA, and in terms of applications, research institutions are the top application area with 28% market share, while biotech companies and universities are also important applications.

This report studies the global Sanger Sequencing Service demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Sanger Sequencing Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Sanger Sequencing Service that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Sanger Sequencing Service total market, 2021-2032, (USD Million)

Global Sanger Sequencing Service total market by region & country, CAGR, 2021-2032, (USD Million)

U.S. VS China: Sanger Sequencing Service total market, key domestic companies, and share, (USD Million)

Global Sanger Sequencing Service revenue by player, revenue and market share 2021-2026, (USD Million)

Global Sanger Sequencing Service total market by Type, CAGR, 2021-2032, (USD Million)

Global Sanger Sequencing Service total market by Application, CAGR, 2021-2032, (USD Million)

This report profiles major players in the global Sanger Sequencing Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Azenta, Eurofins Scientific, LGC Biosearch Technologies, Fasteris, QuintaraBio, Laragen, Microsynth, Nucleics, GenScript Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Sanger Sequencing Service market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Sanger Sequencing Service Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Sanger Sequencing Service Market, Segmentation by Type:
PCR Products
Plasmid DNA
Bacterial Artificial Chromosomes (BAC)
Others

Global Sanger Sequencing Service Market, Segmentation by Application:
Research Institutions
Biotech Companies
Universities and Colleges
Hospitals and Clinics
Pharmaceutical Companies
Others

Companies Profiled:
Thermo Fisher
Azenta
Eurofins Scientific
LGC Biosearch Technologies
Fasteris
QuintaraBio
Laragen
Microsynth
Nucleics
GenScript Biotech
CeMIA
StarSEQ
Source BioScience
Guangzhou Life Technologies DaAn
SciGenom Labs
Psomagen
Tsingke Biotechnology
GenHunter
CD Genomics
Shanghai Personalbio Technology
Suzhou Hongxun Biotechnologies
Guangzhou IGE Biotechnology

Key Questions Answered

1. How big is the global Sanger Sequencing Service market?

2. What is the demand of the global Sanger Sequencing Service market?

3. What is the year over year growth of the global Sanger Sequencing Service market?

4. What is the total value of the global Sanger Sequencing Service market?

5. Who are the Major Players in the global Sanger Sequencing Service market?

6. What are the growth factors driving the market demand? Show more